René Marke

2.6k citations
8 papers · 481 indexed · h-index 4

Impact in

  • Hematology top 5%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
    • Cancer Genomics and Diagnostics

Papers in

René Marke

7 papers receiving 478 citations

Peers

René Marke
Comparison fields: 5 of 51
  • Hematology 289
  • Cancer Research 98
  • Genetics 47
  • Molecular Biology 271
  • Immunology 83
Replace Agnieszka A. Wendorff with:
Agnieszka A. Wendorff United States
Bastien Gerby France
Yebin Ahn United States
Barbara Szymanska Australia
Luca Trentin Italy
Sue Colman United Kingdom
Rachael A. Papa Australia
Lüder Hinrich Meyer Germany
Liliana H. Mochmann Germany
Ruta Grebliunaite United States
René Marke relative to Agnieszka A. Wendorff United States Agnieszka A. Wendorff's profile →
Citations per field
00.5×1.6×
Agnieszka A. Wendorff · 1×
Citations per year

Countries citing papers authored by René Marke

Since Specialization
Citations

This map shows the geographic impact of René Marke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René Marke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René Marke more than expected).

Fields of papers citing papers by René Marke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by René Marke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René Marke. The network helps show where René Marke may publish in the future.

Co-authorship network

The 25 scholars most cited alongside René Marke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with René Marke Line = papers co-authored together René Marke links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 20226
2 201881
3 20180
4 2017349
5 201640
6 20152
7 20131
8 20132

About René Marke

René Marke is a scholar working on Hematology, Cancer Research, Public Health, Environmental and Occupational Health, Molecular Biology and Neurology, having authored 8 papers that have together received 481 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer-related gene regulation (2 papers), Protein Degradation and Inhibitors (2 papers), Extracellular vesicles in disease (1 paper), Retinoids in leukemia and cellular processes (1 paper) and Nuclear Receptors and Signaling (1 paper). The work is most often cited by research in Hematology (289 citations), Cancer Research (98 citations), Genetics (47 citations), Molecular Biology (271 citations) and Immunology (83 citations). René Marke has collaborated with scholars based in Netherlands, Canada and United States. Frequent co-authors include Blanca Scheijen, Frank N. van Leeuwen, Mark D. Minden, Jean Wang, Thomas J. Hudson, Monica Doedens, Liran I. Shlush, John E. Dick, Amanda Mitchell and Gary D. Bader. Their work appears in journals such as Blood, Haematologica, Nature and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026